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Biotechnology offers powerful solutions to the challenges that arise during the design and development
of new complex biomimetic materials to achieve speciﬁc biological responses. Recombinant DNA
technologies, in particular, provide unique solutions in the biomaterials ﬁeld, especially regarding the
control of macromolecular architectures involving protein sequences with the aim of addressing the
multiple functional requirements needed for biomaterials’ applications. Here, elastin-like recombi-
namers are presented as an example of an extraordinary convergence of different properties that is not
found in any other polymer system. These materials are highly biocompatible, stimuli-responsive, show
unusual self-assembly properties and can include bioactive domains along the polypeptide chain.
Applications of these engineered biomimetic polymers in nanotechnological systems, stimuli-responsive
biosurfaces and tissue engineering will be discussed.
 2009 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Polymer science has clearly shown over several decades that
macromolecules are excellent candidates for the creation of highly
functional materials. As a result of the availability of thousands of
different monomers and the multiple possibilities arising from
their different combinations, polymer science has succeeded in
producing a speciﬁc material for a particular application on many
occasions, ranging from very simple materials for use as bulk
commodities to highly sophisticated ones with special biomedical,
engineering or nanotechnological uses. Very few other technical
developments in history have shown the same rapid development
and had the same deep impact on society as polymer science. The
number of different technologies enabled by the existence of
the appropriate polymer is amazing, and the crucial role of polymer
science in the development of modern society and human well-
being is unquestionable.
Most of the synthetic methodologies and the polymers we
produce nowadays are, however, based exclusively on petroleum-
derived chemicals. Although there is no consensus regarding how: þ34 983 184 698.
guez-Cabello).
Y-NC-ND license.many oil reserves remain, it is clear that this resource is ﬁnite and
that its price will continue to increase if wemaintain our increasing
rate of demand. Additionally, we would be well advised not to wait
until the imminent exhaustion of our planet’s oil reserves to reduce
its use as a source of energy and plastics. Growing evidence that the
recent increase in atmospheric CO2 levels is causing a measurable
modiﬁcation of the global climate could, in the mid- to long-term,
lead us to abandon, or at least drastically reduce, oil as our main
source of raw materials for plastics [1]. Polymer science will
therefore soon face a similar reduction in its dependence on oil to
that currently being experienced by the energy sector.
Our current state of technological development and well-being
cannot be maintained by sacriﬁcing the expectations of future
generations-sustainability must therefore also be a key objective in
polymer science. However, we must be fully aware of the actual
meaning of ‘‘sustainability’’. We are obliged to develop sustainable
technologies that fulﬁll the needs of future generations. This does
not mean that we must search for alternative and sustainable
technological solutions, simply to maintain our current level of
development. Therefore, with the degree of technical development
that our grandparents enjoyed, our grandchildren will not be
satisﬁed by a world in which polymers produced from renewable
sources ‘‘only’’ match the performance of the ‘‘old’’ oil-derived
plastics.
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therefore be tackled from all sides. We, as polymer scientists, must
develop technologies to change our current oil-dependence and
unsustainability. This challenge must also be considered an
opportunity to create a new polymer science which, in addition to
being sustainable, will launch a technological revolution that will
lead to new concepts, materials and products which will be more
efﬁcient, functional and than thosewe have today. Part of the aim of
the present manuscript is to present evidence that this purpose is
not just a utopian yearning for a better world and that some signs
that this is possible may already be present.
Our level of technological development has been supported by
a progressive abandonment of natural products and the extensive
use of ‘‘synthetic’’ elements which, in terms of composition and
concept, are far from being natural substances. Paradoxically, one of
the most promising strategies for solving current problems is to
reconsider natural products, or rather to introduce concepts
imported from nature in our future synthetic materials and
systems, and not only for the sake of sustainability. Thus, taking
polymer science as an example, biology discovered long ago that
macromolecules are the best option for obtaining highly functional
materials. Relatively novel concepts in materials science such as
hierarchical organization, mesoscale self-assembly or stimuli-
responsiveness are common to many natural macromolecules such
as proteins, nucleic acids or polysaccharides (or combinations of
them). In fact, the slow but relentless process of natural selection
has produced materials that show a level of functionality signiﬁ-
cantly more complex than that reached by synthetic materials. One
of the best (and nicest) examples of this is the proteins. The
proteins in living cells show an amazing set of capabilities in terms
of functionality, ranging from the structural proteins, all of which
show a signiﬁcant ability to self-assemble, to the extraordinary
enzymes, with their superior catalytic performance, and highly
efﬁcient molecular machines such as the ﬂagellar rotary motor, etc.
Natural proteins are usually large and very complex molecules
which contain diverse speciﬁc functional groups that generate and
promote self-assembly and function. Nature also makes use of
different physical processes that allow directed and controlled
organization from the molecular to the macroscopic level. In
general, both local organization through functional chemical
groups and the physical properties that give rise to order on larger
scales provide the properties and functions that the biological
systems require to function efﬁciently.
Nevertheless, the basis for all of this amazing functionality
displayed by natural proteins seems to be based on one simple
concept, namely a complex and completely deﬁned primary
structure. Protein biosynthesis in living cells occurs with an
absolute control of the amino-acid sequence, from the ﬁrst amino
acid to the last, with a complete absence of randomness. Indeed,
the need for such absolute control becomes dramatically apparent
in some genetic disorders where the lack or substitution of just one
amino acid in the protein leads to a complete loss of the original
function, which can have dramatic consequences in patients with
sickle cell anemia, phenylketonuria and cystic ﬁbrosis [2]. If we
want to create truly functional materials, we must therefore ﬁnd
a way to synthesise complex and completely deﬁned macromole-
cules. This task, which is currently too difﬁcult for even our most
sophisticated chemical methods, occurs routinely in all living cells.
One further characteristic of protein biosynthesis should be high-
lighted at this point, namely that the machinery for protein
biosynthesis is extraordinarily ﬂexible. Ribosomes are able to
process and produce practically any amino-acid sequence stored in
the information elements known as genes, which means that the
ﬂexibility of this process is essentially absolute. From a practical
point of view, if we can therefore somehow control the informationthat genes deliver into the machinery, we can also control the
biosynthesis process itself.
This idea also has remarkable precedents. In the last few years,
signiﬁcant effort has been dedicated to replacing petrochemical-
based chemical processes with biological methods using renewable
resources. Thus, fermentation processes for the production of
biological monomers have been improved by numerous studies
involving the metabolic engineering of microorganisms and the
directed development of enzymes. Suchmicroorganisms have been
widely exploited for medical, agricultural, food and industrial
applications. In addition, they have been engineered to produce
recombinant proteins, amino acids and chemicals for use as drugs
and biofuels [3,4]. For example, various monomers have been
produced via different biological pathways, depending on the
microorganism, from substrates such as succinic acid, lactic acid or
some diols [5]. This process involves the whole metabolic and
regulatory network together with fermentation, recuperation and
subsequent puriﬁcation processes.
The development of new technologies has made it possible to
follow protein expression in cells and tissues through proteomics
and it has allowed researchers to engineer proteins with new
functions that lead to extraordinary technical applications. Nature
has designed proteins with speciﬁc functional properties, such as
the ability to self-assemble, recognition speciﬁcity or mono-
dispersity, and scientists are now starting to exploit and enhance
these properties in protein-based materials. Genetic and protein
engineering provide us with the tools to precisely produce
numerous protein-based polymers far above the current capabil-
ities of synthetic polymer chemistry. These techniques allow us to
synthesize protein chains with absolute control over their molec-
ular mass, composition, sequence and stereochemistry. This is a key
drawback of conventional chemical synthesis, where any increase
in the complexity of the ﬁnal molecule unavoidably leads to an
almost exponential increase in the time and cost of the synthesis.
The use of recombinant DNA technologies to obtain protein-
based polymers with total control of the randomness of the poly-
mer sequence permits us to design the required functionalities of
the ﬁnal biomaterial in a highly precise manner. The success
of engineered protein polymers in material applications will,
however, depend on being able to obtain materials with speciﬁed
physical and chemical properties. As an example of these
approaches, we show here how elastin-like polymers (ELPs) play an
important role in the synthesis of advanced materials, with
a particular emphasis on biomedical and nanotechnological uses.
1.1. Genetic engineering of protein-based macromolecules
In the last few years, the application of powerful molecular
biological methods has allowed the design and synthesis of new
advanced materials almost at will. The use of the 20 naturally
occurring amino acids in the design and production of genetically
engineered functional protein-based macromolecules with speciﬁc
or multifunctional properties offers practically inﬁnite possibilities
and a signiﬁcant number of advantages. First, DNA technologies
allow the introduction of tailored synthetic genes into the genetic
make-up of a microorganism, plant or other organisms which
induces the production of its encoded protein-based polymer as
a recombinant protein [6,7]. These macromolecules offer the
possibility to obtain materials with some of the complex properties
found in natural proteins in combination with functions of partic-
ular technological interest that are not displayed in living organ-
isms. Secondly, the degree of control and complexity attained
by genetic engineering is clearly superior to that achieved by
conventional chemical synthesis. These polymers, for example, are
strictly monodisperse and can be obtained with molecular weights
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has enabled the study of the dependence of different material
properties on molecular mass in a simple and highly precise
manner [9]. Thirdly, the production cost of those materials is not
related to their complexity as the most costly task in terms of both
time and money is the gene construction. However, once the
genetically modiﬁed (micro)organism is obtained, its fast and
cheap production rapidly compensates for the costs associatedwith
the molecular biology steps. This intrinsic advantage also has
environmental beneﬁts as recombinant protein-based materials
are obtained by an easily scalable technology fermentation that
uses only moderate amounts of energy and temperatures, with
water as the only solvent. Finally, the genetic engineering of
protein-based polymers is a relatively new methodology and only
a limited number of research groups and companies have adopted
this approach for their production. Despite the fact that interest in
these materials has mainly concentrated on two major polymer
families, namely spider-silk polymers [10,11] and ELPs [12–16], and
their combinations [17,18], other interesting protein polymers, such
as those based on resilin [19], abductin [20] or gluten [21], among
others, have also been studied.
1.1.1. Some considerations regarding nomenclature
There is no consensus on how those materials should be named.
The term most often used in the literature is ‘‘Recombinant Protein
Polymers’’, although this term is unsuitable for many reasons. First
of all is too long to be of practical use and, more importantly, it is
confusing and does not describe what it tries to. ‘‘Protein polymer’’
can be understood as a polymermade of proteins, which of course is
not the case. These materials are proteins only because they are
produced as recombinant proteins, although their composition is
the result of an engineered design step and the creation of
a synthetic gene which is often totally unrelated to the composition
of any natural protein. In addition, the term ‘‘polymer’’ is not
adequate in most cases. The recombinant materials obtained from
an artiﬁcial gene are normally macromolecules with a molecular
mass comparable to that of conventional polymers. However, these
recombinant materials are in many cases made from huge and
complex monomers that are only repeated a few times (or do not
repeat at all) in the ﬁnal molecule so, despite their high molecular
mass, they should strictly speaking be termed oligomers. In light of
these considerations, we propose the use of a speciﬁc term that can
be speciﬁcally associatedwith this new kind ofmacromolecules and
which is sufﬁciently informative to clearly describe the main char-
acteristics of this emerging class of materials. This term is ‘‘recom-
binamer’’, which clearly indicates the oligomeric nature of these
compounds and their production as recombinant proteins. In
addition, recombinamer strongly resembles the term polymer,
thereby suggesting the macromolecular nature of these materials
but without requiring that they involve a continual repetition of
small and simplemonomers. The term recombinamer also prevents
the reader from automatically identifying these molecules with
natural proteins, or some modiﬁcation thereof, but rather suggests
a molecule whose composition is deﬁned strictly by engineering
design. This termwill therefore be used throughout thismanuscript.
1.1.2. The example of elastin-like recombinamers (ELRs)
ELRs are a promising model of biocompatible protein-based
polymers. The basic structure of ELRs is a repeat sequence found in
the mammalian elastic protein elastin, or a modiﬁcation thereof
[22]. Some of their main characteristics are derived from those
of the natural protein. For example, the cross-linked matrices of
these polymers retain most of the striking mechanical properties
of elastin [23], which becomes important when this behavior
is accompanied by other interesting properties, such asbiocompatibility [24], stimuli-responsive behavior, and the ability
to self-assemble. These properties are based on a molecular tran-
sition of the polymer chains called the inverse temperature tran-
sition (ITT). This transition is the key to the development of new
peptide-based polymers as molecular devices and materials.
The expansion of molecular biology has allowed the design of
complex bioengineered ELRs as well-deﬁned polymers [9,15,25,26].
The most well known members within the ELR family are based on
the pentapeptide VPGVG (or its permutations), and a wide variety
of polymers with the general formula (VPGXG), where X represents
any natural amino acid except proline, have been (bio)synthesized
[15,27,28]. All the polymers with this general formula found in the
literature display functional properties such as acute stimuli-
responsive behavior. The substitution of any of the other amino
acids in the pentamer is not so simple. For example, the ﬁrst glycine
can only be substituted by L-alanine [27].
All functional ELRs exhibit a reversible phase transition in
response to changes in temperature [29]. In aqueous solution, and
below a certain transition temperature (Tt), the free polymer chains
remain disordered, random coils [30] that are fully hydrated,
mainly by hydrophobic hydration. This hydration is characterized
by ordered clathrate-like water structures surrounding the apolar
moieties of the polymer with a structure somewhat similar to that
described for crystalline gas hydrates, although with a more
heterogeneous structure that varies in terms of perfection and
stability [31,32]. Above Tt, however, the chain folds hydrophobically
and assembles to form a phase-separated state containing
63% water and 37% polymer by weight in which the polymer
chains adopt a dynamic, regular, non-random structure known as
a b-spiral, which involves type II b-turns as the main secondary
feature and is stabilized by intra-spiral, inter-turn, and inter-spiral
hydrophobic contacts [27]. This is an effect of the ITT. In this folded
and associated state, the chain loses essentially all of the ordered
water structures arising from hydrophobic hydration. During the
initial stages of polymer dehydration, hydrophobic association of
the b-spirals means they take on a ﬁbrillar form. This process starts
with the formation of ﬁlaments composed of three-stranded
dynamic polypeptide b-spirals which grow to form particles several
hundred nanometers in diameter before settling into a visible
phase-separated state. This folding is completely reversible on
lowering the sample temperature below Tt [27].
However, coacervation can be a complex process that is strongly
inﬂuenced by the composition of the ELP. This is evident, for
example, by examining the molecular and microscopical
phenomena taking place in the coacervation of tropoelastin. Recent
studies suggests the presence of complex structures involved in the
coacervation of the that natural protein. Circular dichroism has
showed the importance of a-helices and subsequent helical side
chain interactions that limit the conformation of tropoelastin
during coacervation [33]. Further, studies support a role for domain
26 [34], a junction between 10, 19, and 25 [35] and more recently
for domain 30 [36].
2. Stimuli-responsiveness and self-assembly properties
of ELRs
The responsive behavior of peptide-based materials has been
deﬁned as their ability to respond to external stimuli. This behav-
iour is even more interesting when the materials show reversibility
at either the structural or functional levels, thereby offering obvious
advantages as stimuli-responsive materials.
The Tt of the ITT can be measured by different techniques, the
most widely used being turbidity measurements and calorimetric
methods that measure the heat ﬂow during the transition.
The turbidity proﬁle and heat ﬂow from a differential scanning
Fig. 2. AFM image of [(VPGVG)2(VPGEG)(VPGVG)2]15 deposited from a water solution
onto a hydrophobic Si substrate. Sample conditions: (A) 10 mg/ml in aqueous 0.02 M
HCl solution (acid solution). (B) 10 mg/ml in aqueous 0.02 M NaOH solution (basic
solution) [43].
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ture in Fig. 1.
The Tt values obtained by these methods often differ depending
on the method, with several factors likely to be responsible for
these differences [16]. In addition, Tt also depends on the molecular
mass, the mean polarity of the polymer [9], and the presence of
other ions and molecules [37–39]. In conclusion, all these factors
make the comparison of Tt values a very delicate matter.
As regards self-assembly, many synthetic strategies have been
developed to obtain advanced devices in an attempt to mimic the
behavior of biology in nature. These techniques have been based on
the concept of self-organization and self-assembly in order to
arrange hierarchically ordered complexes. Both of these mecha-
nisms are widely used by nature and can be exploited in synthetic
devices. Peptides and proteins are useful building blocks to obtain
ordered nanostructures via self-assembly due to their well-stabi-
lized folding, stability, and protein–protein interactions [40].
Natural elastin undergoes a self-aggregation process in its
natural environment, leading to the formation of nanoﬁbrils from
a water-soluble precursor called tropoelastin [27,41]. This ability
resides in certain relatively short amino acid sequences, which are
known to coacervate and form ﬁbrillar aggregates with a high
degree of b-turn structure [42]. The development of genetic engi-
neering techniques has allowed tailored molecular designs of ELRs
with wide-ranging possibilities of being able to form other topol-
ogies and nanostructures to be obtained. Thus, the pH-responsive
ELR [(VPGVG)2(VPGEG)(VPGVG)2]15 is able to form polymer sheets
containing self-assembled nanopores (see Fig. 2) [43].
An atomic force microscopy (AFM) study of the topology of
polymer spin-coated ﬁlms of the Glu-containing ELR, from acid and
basic solutions, onto a hydrophobic Si substrate at temperatures
below Tt has shown that, under acidic conditions, the polymer ﬁlm
shows only a ﬂat surface with no outstanding topological features
(Fig. 2A). When deposited from basic solution, however, the poly-
mer ﬁlm clearly shows an aperiodic pattern of nanopores (width of
approximately 70 nm and separated by approximately 150 nm;
Fig. 2B). This different behavior as a function of pH has been
explained in terms of the different polarity shown by the
g-carboxyl group of the glutamic acid. In the carboxylate form, this
moiety has a markedly higher polarity than the rest of the polymer
domains and the substrate itself. The charged carboxylate groups
therefore impede any hydrophobic contacts in their surroundings,
which is the predominant assembly method for this kind of poly-
mer. These charged domains, along with their hydration sphere,Temperature (in °C)
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Fig. 1. DSC thermogram of poly(VPGVG) (50 mg/ml) in water (heating rate: 5 C/min)
and turbidity proﬁle as a function of temperature for a 5 mg/ml aqueous solution of
the same polymer. The two photographs are taken below (4 C) and above (40 C) the
Tt [16].therefore become segregated from the hydrophobic surrounding,
thus leading to nanopore formation.
3. ELRs as advanced materials for biomedical applications
ELRs show an additional property which is highly relevant for
the use of these polymers as advanced materials for biomedical
applications, namely their extraordinary biocompatibility [24]. In
addition, their biodegradability is obvious as the secondary prod-
ucts of their bioabsorption are simply natural amino acids.
3.1. Nanotechnological systems
The increasing need for drug-delivery systems that improve
speciﬁcity and activity whilst at the same time reducing toxicity to
ensure maximum treatment safety has led to the development of a
wide variety of newmaterials, many of which have been employed
to control the release of drugs and other active agents. Polymeric
systems are, however, often the system of choice because of their
desirable physical properties [44].
Recombinant polymers, such as thermo-responsive ELRs,
represent one of the possible next steps in the development of drug
carriers beyond traditional, synthetic polymers. Elastin biopoly-
mers respond to external stimuli by undergoing a reversible phase
transitionwhere, at temperatures above Tt, the ELR hydrophobically
self-assembles into an insoluble aggregate, thus forming nano- and
microparticles which could be loaded with a drug. The ﬁrst
ELR-based drug-delivery system was a simple device in which
g-radiated cross-linked poly(VPGVG) hydrogels of different shapes
were loaded with a model water-soluble drug (Biebrich Scarlet),
whichwas released by diffusion. Additionally, the inclusion of some
glutamic acids along the polymer chains was used to control the
hydrolyzable cross-linking. The cross-linking was of the carboxy-
amide type and the drug was released as these cross-links were
hydrolyzed at a given rate [45]. Poly(VPAVG) nano- and micropar-
ticles have also been tested as carriers of the model drug
dexamethasone phosphate in order to develop injectable systems
for controlled drug release [46]. Nanoparticles with a diameter of
around 300–400 nm have recently been obtained from ELRs by
a novel application of the electrospray technique to encapsulate
drugs. Themorphology and size of these polymer nanoparticles can
be controlled by varying the composition, molecular mass, and
solvent, amongst others [47]. In other recently study, nanoscale
protein particles with less than 100 nm in diameter were con-
structed using temperature-sensitive ELR and polyaspartic acid
chain under physiological conditions. The critical temperature of
formation of the particle can be adjusted by the lengths of the
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temperature is required, it is only necessary to elongate the
ELR [48].
ELRs are particularly attractive for the synthesis of block
copolymers that self-assemble into polymer nanostructures such
as micelles. The ﬁrst work in this area involved an elastin-mimetic
di-block copolymer containing VPGEG–(IPGAG)4 and VPGFG–
(IPGVG)4 as the hydrophilic and hydrophobic blocks, respectively
[49]. The resulting micelles were studied by dynamic light scat-
tering (DLS) and DSC was used to measure the enthalpy of
self-assembly. A tri-block copolymer was subsequently synthesized
and the TEM images of this polymer showed that it formed
spherical aggregates [50]. Other multivalent spherical micelles
have been obtained from linear elastin-like AB di-block copolymers
in the temperature range 37–42 C with the aim of targeting cancer
cells [51]. Bidwell et al. have also exploited the ELRs for its ability to
serve as macromolecular carriers for thermally targeted delivery of
drugs. Attachment of doxorubicin to ELR-based system showed
enhanced cytotoxicity in uterine sarcoma cells when aggregation
was induced with hyperthermia [52].
We have also synthesized amphiphilic di- and tri-block copoly-
mers to study the micelle self-assembly process. These block
copolymers contain two different blocks: one with the monomer
[(VPGVG)2-(VPGEG)-(VPGVG)2] (E-block) and the second with
the monomer [(VPGAVG)m] (A-block). Both these blocks are thermo-
responsive and the E-block is also pH-responsive [53]. The sponta-
neous formation of nanostructures can therefore be controlled by
changing both the pH and the temperature, and vesicles with
different sizes have been obtained [54] (Fig. 3).
3.2. Biosurface engineering
Surface engineering is an important tool for understanding the
molecular mechanisms involved in protein adsorption and cell–
surface interactions. The design and control of these features is
a key challenge for diverse speciﬁc biological applications [55,56].
Multiple approaches involving physical and chemical modiﬁca-
tions, such as coatings and grafts or the introduction of small
biological ligands (peptides or proteins), have been developed in
the surface engineering of biomaterials [55–59]. These approaches
allow surfaces to be functionalized with fouling-anti fouling
features, speciﬁc groups for cell–material interactions, responsive
behavior (stimuli or environmentally sensitive), or with micro- and
nano-patterns.
3.2.1. Functionalized surfaces with ELRs
The modiﬁcation of surfaces with stimuli-responsive poly-
mers that vary their physical and chemical properties inFig. 3. Cryo-TEM images in aqueous solution: (A)response to changes in their environment or external stimuli
makes these polymers excellent candidates for the development
of stimuli-responsive surfaces [60–62]. In most cases, the surface
is grafted with derivatives of poly(N-isopropylacrylamide),
a well-known thermo-sensitive polymer. ELRs exhibit some
additional advantages that make them excellent candidates for
the development of responsive surfaces. Therefore, Ozturk et al.
have prepared recently micropatterned pNIPAM ﬁlms as thermo-
responsive cell carriers. They were chemically modiﬁed by ELR
adsorption containing RGD amino acid sequence to promote cell
adhesion. They have studied the thermal responsiveness to apply
mechanical stress on cells under in vitro conditions to induce
bone formation showing that ELR is crucial for maintaining the
cells attached on the surface in dynamic culturing [63]. For
instance, genetic engineering allows them to be designed with
extraordinary control of the sequence and with desirable prop-
erties, which means that in addition to their thermo-responsive
behavior they can also respond to other stimuli such as pH, light,
or ionic strength, amongst others. On the other hand, biosyn-
thesis enables precise control of the reactive sites on the poly-
peptide chain for use in surface grafting. For example, the
nanometric control of their position leads to a tremendous
potential for self-assembly and other functionalities displayed by
these systems. Biosensing surfaces can take advantage of the
reversible phase-transition behavior of ELRs to obtain an active
surface whose properties such as hydrophobicity and function-
ality can be quickly modulated by a simple temperature change.
However, in spite of the enormous potential of these biopoly-
mers, there are only a few examples of surfaces functionalized
with ELRs, one of which makes use of the above-described
topologically modiﬁed self-assembly ability of the recombinant
ELR [(VPGVG)2-(VPGEG)-(VPGVG)2]15. Thus, by covalently
micropatterning ELRs onto glass surfaces, Chilkoti’s group has
created what they have called ‘‘thermodynamically reversible
addressing of proteins’’ (TRAP) [55,61]. This allows the revers-
ible, spatio-temporal modulation of protein binding at a solid-
liquid interface and can be applied in different systems for
bio-analytical devices.
Other techniques used for ELRs include layer-by-layer deposi-
tion of alternating ELR-polyelectrolytes, which is a simple tech-
nique to generate bioactive surfaces [64]. These ultra-thin
nanoscale coatings promote cell adhesion and proliferation and the
results show that the thickness and mechanical integrity of the
multilayer assembly modulates the cell response. Costa et al., for
example, have developed thermo-responsive thin coatings using
electrostatic self-assembly (ESA). A recombinant ELR containing the
cell attachment sequence RGD has been deposited onto chitosan
and has been found to show enhanced cell adhesion in comparisonE50A60E50, (B) E50A60. Scale bars: 200 nm.
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These examples open up the ﬁeld of polymeric coatings that
include speciﬁc biofunctional responses.
3.2.2. Nano- and microtopographical surfaces
In the last few years the combination of surface chemistry with
microfabrication techniques has provided new tools to study the
interactions of cells with their environment. Using lithography and
patterning techniques, peptides and proteins can be deposited with
complete spatial control on speciﬁc regions of a surface [66,67]. The
ability to obtain nano- and micrometer-sized patterns of biological
macromolecules is of great importance for several applications,
including biological assays, miniaturized biosensors, and biomed-
ical diagnostics.
ELRs have been employed in the design and development of
regenerable biosensors and microﬂuidic bioanalytical devices, as
reported by Chilkoti et al. [68]. Thus, nanostructured surfaces that
are able to capture and release proteins using the self-assembly
properties of ELRs have been obtained by combining ELRs and dip-
pen nanolithography.
In our group, we have adapted the simple method of replica
molding to obtain 3D microstructured thermo-responsive hydro-
gels [69]. Replica molding is a fast, ﬂexible, and straightforward
micropatterning technique that can be carried out routinely and
consists of only a few steps: dispensing of the polymer on the mold,
cross-linking, and release of the replica ELR hydrogel. In this study,
which aimed to test the thermally responsive behavior of macro-
scopic and micropatterned features, we obtained hydrogels with
micropatterns such as lines or pillars with different dimensions and
spacings (see Fig. 4).
The dimensions of the microfeatures with micropatterned lines
were tested with respect to the water temperature, with a 30–35%
decrease in dimensions being observed for both patterns at
a temperature above the transition temperature of the hydrogels
(20 C). This thermo-responsive behavior does not modify the
topography and can be used to change the dimensions of the
micropatterned features during cell culture. Furthermore, theseFig. 4. Optical micrographs of different micropasystems permit controlled topography to be added as a further
factor for studying cell behavior and cell-surface interactions,
thereby improving the extraordinary properties of ELR hydrogels,
particularly their bioactivity, biocompatibility, and the ‘‘tunability’’
of their mechanical properties.
The ability to generate micro/nanoscale features with
synthetic and natural polymers has been improved by using
a simple fabrication technology known as electrospinning
[70,71]. This process has been widely used in the textile industry
and organic polymer science and has now reappeared as a novel
tool for fabricating biopolymer scaffolds [72–74]. The electro-
spinning process involves applying a high voltage to create an
electrically charged jet of polymer solution, which dries to leave
a polymer nanoﬁber mesh. The ﬁbers produced by this process
usually have diameters on the order of a few micrometers down
to less than a hundred nanometers. Their structural properties
depend on processing parameters such as polymer concentration
and viscosity, ﬂow rate, and applied voltage, amongst others
[75]. The ability to vary ﬁber size in the nanometer range opens
up the possibility of mimicking the size scale of ﬁbrous proteins
found in the natural extracellular matrix. Indeed, ﬁbers made
from different proteins such as ﬁbrinogen [76], gelatin [73],
collagen–elastin mixtures [77], or silk-like proteins [78] have
been obtained. The ﬁrst elastin-mimetic protein ﬁbers were
produced from a genetically engineered ELR [79]. Different
morphological patterns, such as beaded ﬁbers, thin ﬁlaments, or
broad with a ribbon-like appearance, were obtained by varying
the solution concentration. To date, electrospun elastin analogs
have only played a key role in modulating the viscoelastic
properties of the resulting blended material the inclusion of
bioactive domains in their structure has not been reported. We
have also exploited this technique to obtain nanoﬁbers from an
aqueous solution of multifunctional recombinant ELRs contain-
ing cell-attachment sequences [80]. These ﬁbers were chemically
cross-linked after deposition and immersed in water to study
their morphology. Fig. 5 shows the SEM micrographs of our ELR
nanoﬁbers.tterned hydrogels. Scale bars: 50 mm [69].
Fig. 5. SEM micrographs of ELR nanoﬁbers: A) as-deposited ﬁbers; B) cross-linked ﬁbers. Scale bars: 5 mm.
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after the cross-linking reaction. These substrates were tested in
different cell human lines and showed interesting properties in
terms of cell adhesion. An ELR with a similar composition but
lacking bioactive domains has shown non-fouling properties,
thereby suggesting future applications where nonspeciﬁc adhesion
could be desirable [80].
4. Tissue engineering
The design of functional biomaterials that induce a speciﬁc
cellular response is a major challenge in the ﬁeld of materials
science. Methods for fabricating stimuli-responsive biomaterials
have allowed these materials to play a more interactive role in
tissue engineering [81,82]. However, there are several requirements
that a biocompatible material should provide to promote cell
attachment, differentiation, and proliferation. Thus, the scaffold
must be biocompatible and biodegradable and it should show
properties that support tissue morphogenesis. This generally
requires an artiﬁcial extracellular matrix that can supply temporary
mechanical support until the engineered tissue has sufﬁcient
mechanical integrity to support itself.
The extracellular matrix (ECM), which contains a complex
composition of ﬁbrous proteins and heteropolysaccharides, is an
important model for biomaterials’ design. Recombinant DNA
technologies allow the design and expression of artiﬁcial genes to
prepare artiﬁcial analogues of ECM proteins with controlled
mechanical properties that incorporate domains to modulate
cellular behavior [83]. Future advances in tissue engineering will
depend on the development of biomimetic materials that actively
participate in the formation of functional tissue.
The ﬁrst candidate ELRs for tissue engineering were poly-
(VPGVG) and their cross-linked matrices [12]. These materials were
tested for cell adhesion and it was found that cells did not adhere to
them. This provided a starting point to obtain key biomaterials
which maintain their biocompatibility and adequate mechanical
properties but lack nonspeciﬁc bioactivity. The subsequent incor-
poration of active peptides as cell-adhesion ligands resulted in
a high capacity to promote cell attachment. These bioactive
(VPGVG) derivatives containing the general adhesion peptides RGD
and REDV, the latter of which is speciﬁc for endothelial cells,
showed similar cell attachment behaviors to human ﬁbronectin
[84]. Once genetic engineering was adopted as the production
method of choice, the molecular designs started to increase in
complexity. The addition of different functionalities as cross-link-
ing domains facilitates the attainment of more uniform substrates,
which are usually based on lysine residues incorporated in the
elastin-based repeat unit (VPGXG) [23,26,85]. ELR hydrogelsproduced by photoinitiation [86], irradiation [87,88], amine reac-
tivity [13,23,26,85,89–93], and enzymatic cross-linking by tissue
transglutaminase [94] show interesting properties as stimuli-
responsive substrates. These hydrogels are a new class of soft
materials which, in response to a small change in temperature,
light, or other environmental stimulus, swell to several times their
original volume or shrink to the same degree [81,95]. These
materials have proved extremely useful in biomedical and phar-
maceutical applications due to their high water content and
rubbery nature, which is similar to that of natural tissue.
Chemical cross-linking in organic solvents leads to the forma-
tion of more uniform hydrogels as the ELR molecules exhibit no
inverse phase transition. McMillan et al., for example, have used
a bis(sulfosuccinimidyl) suberate cross-linker to join ELRs con-
taining lysine residues in phosphate buffer at pH 8.5 or in dimethyl
sulfoxide. These authors studied the effect of the solvent on the
cross-linking density and the gel structures [91,92]. The physical
properties of chemically cross-linked hydrogels can be modulated
by varying the ELR’s molecular mass, concentration, and lysine
content. This ability to prepare ‘‘tunable’’ hydrogels allows these
ELRs to be used in a wide range of applications [96]. Although there
are many examples of ELR hydrogels cross-linked in organic
solvents, the application of in situ cross-linking in an aqueous
medium is limited by factors such as the toxicity of the reagents and
byproducts and slow gelation kinetics. Lim et al. have reported that
the chemical gelation of ELRs in physiological conditions provides
a biocompatible and injectable biomaterial for support-tissue
regeneration [93].
In our group, Girotti et al. have bioproduced the ELR polymer
[(VPGIG)2-VPGKG-(VPGIG)2-(EEIQIGHIPREDVDYHLPY)-(VPGIG)2-
VPGKG-(VPGIG)2-(VGVAPG)3]n (n¼ 10; MW¼ 80925 Da) [7]. The
monomer unit contains four different functional domains in order to
achieve an adequate balance between mechanical and bioactive
responses. The (VPGIG)n sequence in this material confers its excel-
lent mechanical properties, extreme biocompatibility, and stimuli-
responsive nature. The second building block is a modiﬁcation of the
ﬁrst, with a lysine instead of isoleucine, which means that the lysine
e-amino groups can be used for cross-linking and other chemical
modiﬁcationswhilst retaining the properties of ELRs. The third group
contains the (REDV) peptide sequence foundwithin the alternatively
spliced CS5 ﬁbronectin domain, which is speciﬁcally recognized by
the integrin a1b4 [97]. This integrin is present in a few cell lines and
its speciﬁcity for REDV tetrapeptide has been conﬁrmed in endo-
thelial cells, which selectively bind to REDV-coated surfaces [98].
Finally, the polymer possesses another functional block, in this case
a recurring hexapeptide derived from the human elastin exon 24-
encoded product (VGVAPG)3 [99]. This sequence was introduced to
drive enzymatic hydrolysis of the synthetic scaffold by the same
Fig. 6. SDS-PAGE analysis of ELR proteolysis: A) digested fragments obtained at different incubation times; B) tricine SDS-PAGE is used to separate the resulting total digestion
fragments. The numbers at the side of the images indicate the position and size of the molecular mass protein marker.
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it is a target for certain proteolytic enzyme elastases [99].
REDV–ELR biopolymer biodegradationwas testedwith a speciﬁc
protease, namely human leukocyte elastase I (Fig. 6). When
recombinant ELRs were incubated under optimal enzymatic
conditions the elastase was found to quickly and completely digest
the REDV biopolymer and no signiﬁcant degradation of the control
biopolymer (lacking the target hexapeptide) was observed even
when extending the experimental time (Fig. 6A).
The molecular mass of the bands produced in a complete
digestion was analyzed in tricine SDS-PAGEs [100]. This electro-
phoresis method allows us to separate bands corresponding to
proteins and/or peptides with a molecular mass of less than
9000 Da. The bands of the ELR proteolytic fragments resulting from
complete enzymatic hydrolysis were found to possess a similar
molecular mass to that of the theoretical fragments produced by
speciﬁc elastase proteolysis (Fig. 6B).
We have also tested the adhesion of human umbilical vein
endothelial cells (HUVECs) to chemically cross-linked ELR ﬁlm
scaffolds containing REDV adhesion sequences and to a negativeFig. 7. Microscopy images of HUVECs seeded on ELR ﬁlms aftercontrol (lacking the bioactive sequences) [101]. On REDV–ELR
scaffolds the cells showed a spread morphology with the cyto-
skeleton actin ﬁlaments (stained green) well organized into stress
ﬁbers, which is indicative of strong adhesion (Fig. 7A). The cell
number and morphology of the HUVECs seeded on the ELR-nega-
tive control were completely different from those seeded on the
REDV scaffold, with few smaller and rounded cells with minor
lamelopodia extensions, thus indicating that passive adhesion was
the main cell–scaffold interaction (Fig. 7B).
This ELR-containing REDV cell-adhesion sequence has also been
used to prepare hybrid scaffolds [102] as the introduction of ELR as
an elastic element in collagen-based scaffolds enhances their
mechanical properties. In this study, enzymatic cross-linked ELR-
collagen scaffolds were tested in vitro as substrates to study cell
viability with different cell lines. An increasing ELR fraction in the
scaffold was found to have an antifouling effect in ﬁbroblasts,
whereas endothelial cells displayed normal behavior and prolifer-
ation in the hybrid scaffolds. Varying the proportion of both
materials should allow us to design the optimal requirements for
future applications, such as vascular tissue or skin wound healing.16 hours of incubation: A) REDV ﬁlm; B) negative control.
Fig. 8. ESEM micrographs showing the change in pore-size with temperature in swollen hydrogels in water: A (4 C); B (55 C). Scale bars: 100 mm.
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polymers chemically cross-linked with hexamethylene diisocya-
nate have been obtained by the salt leaching/gas foaming tech-
nique for use in 3D cell culture [103]. The pore size of these gels
can be controlled by varying the size of the salt particle incorpo-
rated during the cross-linking reaction. Physical properties such as
the porosity, swelling ratio, and mechanical properties are also
inﬂuenced by the salt/polymer weight ratio. The thermal behav-
iour of these gels was also studied in terms of the physical prop-
erties. Thus, the swollen hydrogels were heated to test the effect
on the pore size (see Fig. 8). The collapse observed due to the
phase transition above Tt decreased the mean pore size by about
30%. This technique should provide a simple approach to the
fabrication of advanced scaffolds with ‘‘tunable’’ biological and
physical properties in which the elasticity and thermo-responsive
behaviour expand the range of potential applications of these
materials.
Reverse thermosensitive polymers are very promising base
materials for ‘‘in situ generated implants’’. The ability to produce
low viscosity physiological solutions at room temperature which
form a gel at higher temperature opens up numerous possibilities,
although these are normally directed in two main directions:
hydrophobic materials which acquire desired mechanical prop-
erties or water-based systems for the controlled release of
hydrophilic macromolecules. The structural complexity of ELRs
with speciﬁc mechanical, chemical, and biological properties
allows us to design speciﬁc features that make it possible to
acquire some or all of these properties. The self-assembly
behavior of ELRs, for example, has been triggered by the addition
of different main peptide blocks in the structure. Thus, hydrophilic
blocks provide conformationally elastic properties whereas
hydrophobic blocks form physical cross-links through hydro-
phobic aggregation (see Fig. 9).Fig. 9. Hydrophobic aggregation scheme of ELR tri-block copolymers in aqueous
systems.In a recent example, ELR tri-block copolymers with different
hydrophobic architecture were found to form gels with a complex
shear modulus ranging from 4.5 to 10.5 kPa and which can be
increased by changing the hydrophilicity of the inner block [104].
This elastic modulus has been enhanced by including additional
chemical cross-linking sites in the polymers’ composition [105],
thus making them excellent candidates for biomedical
applications.
5. Conclusions
The goal of replacing current oil-based chemical processes with
biological methods has resulted in the development of a method to
produce complex recombinamers with a well-deﬁned sequence
and complete control of the molecular architecture. In this review
we have summarized some examples that demonstrate the versa-
tility of ELRs for a wide range of applications. The potential of ELRs
to self-assemble in response to environmental changes makes
them attractive for the construction of nano-devices for use as
controlled delivery systems, stimuli-responsive biosurfaces, or
advanced nanobiotechnological applications. The tailored intro-
duction of cross-linking groups, cell-binding domains, and enzy-
matic biodegradation along the polypeptide chain makes these
materials excellent substrates which can be used to mimic some of
the most important characteristics of the ECM for tissue engi-
neering. Thus, ELR hydrogels are promising candidates in terms of
microstructure, ‘‘tunable’’ mechanical properties, and topography
for the study of cell behavior and cell–surface interactions, which is
an important step towards the development of cell-based
biomedical systems.
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